immungene.com

Home

Welcome to ImmunGene, Inc. Next generation targeted protein therapeutics. Im munGene, Inc. is a privately held drug discovery and development company, developing next generation of monoclonal antibody-based therapeutics to treat cancer, autoimmune creating disorders and other diseases. We are leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are highly optimized for efficacy and a superior safety profile. August 6, 2015. November 7, 2013. There is ...

http://www.immungene.com/

OVERVIEW OF immungene.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNGENE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 9 reviews

5 star

5

4 star

0

3 star

2

2 star

0

1 star

2

Hey there! Start your review of immungene.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT IMMUNGENE.COM

Sanjay Khare

5380●●●●pisa

thou●●●●oaks , California, 91320

UNITED STATES

805●●●131

sa●●●●●●●●●@inbox.com

View this contact

Sanjay Khare

5380●●●●pisa

thou●●●●oaks , California, 91320

UNITED STATES

805●●●131

sa●●●●●●●●●@inbox.com

View this contact

Sanjay Khare

5380●●●●pisa

thou●●●●oaks , California, 91320

UNITED STATES

805●●●131

sa●●●●●●●●●@inbox.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2007 October 18
UPDATED: 2013 November 23
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

16

YEARS
6

MONTHS
20

DAYS

NAME SERVERS

1: ns47.domaincontrol.com
2: ns48.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

7

SSL

EXTERNAL LINKS

2

SITE IP

104.146.232.61

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Home | immungene.com Reviews

<META> DESCRIPTION

Welcome to ImmunGene, Inc. Next generation targeted protein therapeutics. Im munGene, Inc. is a privately held drug discovery and development company, developing next generation of monoclonal antibody-based therapeutics to treat cancer, autoimmune creating disorders and other diseases. We are leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are highly optimized for efficacy and a superior safety profile. August 6, 2015. November 7, 2013. There is ...

<META> KEYWORDS

1 follow

2 pageheader

3 immungene inc

4 currently selected

5 about us

6 management

7 directors

8 scientific advisory board

9 technology

10 about cmabs

CONTENT

Page content here

KEYWORDS ON PAGE

follow,pageheader,immungene inc,currently selected,about us,management,directors,scientific advisory board,technology,about cmabs,our competitive edge,pipeline,partnering,news,careers,default,page content,our approach,our focus,latest news,pagefooter

SERVER

Microsoft-IIS/10.0

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | immungene.com Reviews

https://immungene.com

Welcome to ImmunGene, Inc. Next generation targeted protein therapeutics. Im munGene, Inc. is a privately held drug discovery and development company, developing next generation of monoclonal antibody-based therapeutics to treat cancer, autoimmune creating disorders and other diseases. We are leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are highly optimized for efficacy and a superior safety profile. August 6, 2015. November 7, 2013. There is ...

INTERNAL PAGES

immungene.com

1

Management

http://www.immungene.com/about-us1/directors

Turn on more accessible mode. Turn off more accessible mode. Skip to main content. Sanjay D. Khare, PhD. President and CEO, Chairman of the Board. Michael J. Gresser, PhD. Chief Scientific Officer, ImmunGene Board Member and SAB Member. Raj K Sachdev, PhD. Chief Operating Officer, ImmunGene Board Member . Linda M. Pullan, PhD. Consultant Chief Business Officer. John H. Tran. Consultant Chief Financial Officer. 480 Constitution Ave,. Camarillo, CA 93012.

2

Scientific Advisory Board

http://www.immungene.com/about-us1/directions

Turn on more accessible mode. Turn off more accessible mode. Skip to main content. Lieping Chen, MD, PhD. Director of Cancer Immunology,. The Yale Cancer Center, . Yale University School of Medicine . Richard A. Flavell, PhD, FRS. Chairman, Sterling Professor of Immunobiology, . Yale University School of Medicine. Sherie L. Morrison, PhD. Chairwoman, Department of Microbiology, Immunology and Molecular Genetics, UCLA . Dennis Fenton, PhD. 480 Constitution Ave,. Camarillo, CA 93012.

3

About Us

http://www.immungene.com/about-us1

Turn on more accessible mode. Turn off more accessible mode. Skip to main content. Our leadership has deep experience in the development of therapeutic antibodies, protein engineering, manufacturing of biologics, business development, and has been successful in major biotech and biopharmaceutical companies such as Amgen, Genentech, Merck, Baxter, Astra Zeneca. 480 Constitution Ave,. Camarillo, CA 93012.

4

Development Pipeline

http://www.immungene.com/clinical-pipeline

Turn on more accessible mode. Turn off more accessible mode. Skip to main content. Which is a joint venture formed by ImmunGene, Inc. and . Our candidate, IGN004, comprises a monoclonal antibody against a novel tumor target genetically linked to immune effector molecule. This target is expressed on hematological malignacies, multiple solid tumors, including melanoma, and non-small cell lung cancer. Our lead drug candidate has demonstrated efficacy in high-bar animal models. Our IGN005 candidate comprises...

5

News

http://www.immungene.com/news

Turn on more accessible mode. Turn off more accessible mode. Skip to main content. January 8, 2016. Valor Biotherapeutics Announces First Patient Treated in Phase 1 Study of IGN002. August 6, 2015. Valor Biotherapeutics to Begin Phase 1 Clinical Study of Novel Lymphoma Therapy. November 7, 2013. ImmunGene Raises $9 Million in Series A Financing. June 3, 2013. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein. By Tzu-Hsu...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

valorbiotherapeutics.com

Valor Biotherapeutics

http://www.valorbiotherapeutics.com/index.html

Advancing Next Generation of Antibody-based therapeutics. Welcome to Valor Biotherapeutics. Valor Biotherapeutics is a joint venture between ImmunGene, Inc. And Caliber Biotherapeutics, LLC. Focused on the clinical development and commercialization of next generation of monoclonal antibody-based therapeutics to treat cancer. 11/07/2013 ImmunGene Raises $9 Million in Series A Financing. 02/11/2011 ImmunGene's Interferon Payload Technology Platform Featured in BioCentury Magazine. ImmunGene technology allo...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

immunfit-forever.com

Dr. Petra Sommer-Verlag

Ihr Warenkorb ist leer. Dr Petra Sommer wurde in dem kleinen Hessenstädtchen Haiger am Rande des Westerwaldes geboren. Schon früh reifte der Wunsch in ihr heran, Ärztin zu werden. Das Universitätsstudium in Marburg und die anschließende Kra. Nkenhauszeit desillusionierte sie jedoch ein wenig. Erst in der Naturheilpraxis erfuhr sie durch die komplementäre Medizin (Kombination von Schulmedizin und Naturheilverfahren), welch phantastische Möglichkeiten es gibt, die Gesundheit der Menschen zu stärken und...

immunfluoreszenz.de

EUROIMMUN Medizinische Labordiagnostika AG: German

This is the default web page for this server. The web server software is running but no content has been added, yet.

immunforsvar.dk

Immunforsvar.dk - Læs alt hvad der er værd at vide om immunforsvaret

Immunforsvar.dk - Læs alt hvad der er værd at vide om immunforsvaret. Hvordan styrker man det? Hvordan styrker man det? Velkommen til Immunforsvar.dk. Her på siden samler vi alt info vedrørende kroppens primære forsvar - immunforsvaret. Find info om hvad immunforsvaret er. Her på siden har vil lavet en lille beskrivelse, som giver et indblik i hvad et immunforsvar egentlig er. Få tips og trick til at styrke dit eget immunforsvar. Immunforsvaret – din krops eget forsvarssystem. Immunforsvarets celler angr...

immunforte.hu

Quaestor Bank - Rólunk

Elszámolási és forintosítási információk. A Magyar Nemzeti Bank (MNB) engedélyével a QUAESTOR Értékpapírkereskedelmi és Befektetési Zrt. 100 százalékos részesedést szerzett a Credigen Bankban. Ennek megfelelően elindultak az átalakítási folyamatok, amelyekről a későbbiekben tájékoztatjuk az érdeklődőket. Addig is látogasson el weboldalunkra és ismerjen meg bennünket:. Https:/ www.quaestor.hu/penzugyek. A QUAESTOR Bank Zrt. Természetesen a QUAESTOR Bank Zrt. 36 1) 453 5111. 36 1) 453 5101. 06 1 453 5111.

immungen.com

immungen.com - immun.gen.tr | Sitemiz yapım aşamasındadır.

İMMÜNGEN Biyoteknoloji ve Yaşam Bilimleri AR-GE. Altıntepe Mh. Galipbey Cd. Meşe Sk. No.18/2 Maltepe / İSTANBUL. 1025 Sk. 74 Blok D.24 Evka 4 Bornova / İZMİR. 0 (216) 388 92 75 - 0 (532) 302 85 94.

immungene.com

Home

Welcome to ImmunGene, Inc. Next generation targeted protein therapeutics. Im munGene, Inc. is a privately held drug discovery and development company, developing next generation of monoclonal antibody-based therapeutics to treat cancer, autoimmune creating disorders and other diseases. We are leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are highly optimized for efficacy and a superior safety profile. August 6, 2015. November 7, 2013. There is ...

immungenetics.com

Immungenetics AG | Developing effective treatments for devastating diseases: Neurodegeneration, Inflammation, Mitochondrial Dysfunctions, Aging

Skip to main content. Developing effective treatments for devastating diseases: Neurodegeneration, Inflammation, Mitochondrial Dysfunctions, Aging. Developing effective treatments for devastating diseases: Neurodegeneration, Inflammation, Mitochondrial Dysfunctions, Aging. 2015 Immungenetics. created by auttec.de.

immungenetik-kl.de

Unternehmen - Institut für Immunologie und GenetikInstitut für Immunologie und Genetik | Kaiserslautern

Institut für Immunologie und Genetik. Prof Dr. med. Wolfram Henn. Dr med. Sabine Hentze. Wir freuen uns über Ihr Interesse an unserem Labor. Auf diesen Seiten finden Sie einen Einblick in unser Leistungsspektrum, mit modernsten labordiagnostischen Verfahren und kompetenter Beratung. Wir legen großen Wert auf Patientenzufriedenheit und individuelle Beratung und Betreuung. Sollten Sie die gewünschten Informationen nicht finden, kontaktieren Sie uns bitte telefonisch oder per Email.

immungenetik.de

Ziele

Der Förderung der Forschung und Lehre auf dem Gebiet der Immungenetik und Histokompatibilitätstestung und ihrer Anwendung in der Klinik. Der Durchführung von und Beteiligung an wissenschaftlichen Veranstaltungen (z.B. Kongressen und Symposien). Der fachlichen und wissenschaftlichen Beratung von medizinischen Gesellschaften, Behörden und Organisationen. Institutionen der Transplantationsmedizin und deren Grenzgebieten. Der Zusammenarbeit mit fachverwandten Gesellschaften.

immunglimt.no

ImmunGlimt | Om kroppens evige kamp for å overleve

Om kroppens evige kamp for å overleve. Skip to primary content. Skip to secondary content. August 4, 2015. Norway Cup er nettopp avsluttet. I en uke har barn og unge kledd i fargerike fotballdrakter kjempet om ballen mens håpefulle foreldre og trofaste supportere har stått på sidelinjen og heiet. Det får meg til å tenke på hva antistoffer kan brukes til. Kan sammenliknes med klær. Kan i prinsippet lage antistoffer mot alle strukturer som normalt ikke finnes i kroppen. Antistoffer kan merkes med ulike flu...

immunglobulin.com

STRATO